Patent details

EP1853719 Title: ENZYMATIC TRANSFORMATION OF A PROSTAGLANDIN (BIMATOPROST) INTERMEDIATE

Basic Information

Publication number:
EP1853719
PCT Application Number:
PCT/US/2006/008129
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP067373134
PCT Publication Number:
WO/2006/094294
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ENZYMATIC TRANSFORMATION OF A PROSTAGLANDIN (BIMATOPROST) INTERMEDIATE
French Title of Invention:
TRANSFORMATION ENZYMATIQUE D'UN PRODUIT INTERMEDIAIRE DE LA PROSTAGLANDINE (BIMATOPROST)
German Title of Invention:
ENZYMATISCHE UMWANDLUNG EINES PROSTAGLANDIN (BIMATOPROST)-ZWISCHENPRODUKTES
SPC Number:

Dates

Filing date:
06/03/2006
Grant date:
02/09/2009
EP Publication Date:
02/09/2009
PCT Publication Date:
08/09/2006
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
14/11/2007
EP B1 Publication Date:
02/09/2009
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
06/03/2010
Expiration date:
06/03/2026
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
06/03/2006
 
 

Name:
Teva Pharmaceutical Industries Ltd
Address:
5 Basel Street PO Box 3190, 49131 Petah Tiqva, Israel (IL)

Inventor

1

Name:
FISHMAN Ayelet
Address:
Israel (IL)

2

Name:
EFFENBERGER Reinhard
Address:
Israel (IL)

Priority

Priority Number:
659009 P
Priority Date:
04/03/2005
Priority Country:
United States (US)

Classification

Main IPC Class:
C12P 31/00;
Filing date Document type Number of pages